Author(s):
Ghuffran Muhammed Hassan, Hayder Z. Ali
Email(s):
h.z.ali@scbaghdad.edu.iq
DOI:
10.5958/0974-360X.2020.00670.8 
Address:
Ghuffran Muhammed Hassan, Hayder Z. Ali*
Department of Biology, College of Science, University of Baghdad, Al-Jaderyia Campus, Baghdad, Iraq.
Assistant Prof., Molecular Parasitologist, Dept. of Biology, College of Science, University of Baghdad, Al-Jaderiya Campus, Baghdad, Iraq.
*Corresponding Author
Published In:
Volume - 13,
Issue - 8,
Year - 2020
ABSTRACT:
Leishmania parasites are the causative agent of leishmaniasis. Many studies are inspecting chemical drugs, including the use of miltefosine and amphotericin B, but curative values may be limited for these drugs with side effects due to the chemical origin, therefore, investigating less toxic therapies is essential. The aim of this study was to investigate the effectiveness of artemisinin on Iraqi strain of Leishmania tropica, by experimental macrophage ex vivo infection of amastigotes into mouse macrophage cell-line RAW264.7. Different concentrations (100, 200, 300, 400, 500)µM of artemisinin (ART) were screened to examine the susceptibility of L. tropica amastigotes to invade macrophage cell line along three times of follow up (24, 48 and 72) hours. Results showed that artemisinin had a cytotoxic effect on the parasite in which a significance difference (P = 0.05) in cell viability was observed and IC50 was calculated as 182.6 µM after 48 hours treatment. In addition, percentage of infectivity of intracellular amastigotes was significantly decreased. These findings revealed the potential efficacy of artemisinin against the infectious amastigotes and can be further studied to screen its effectiveness in vivo for exploring a safer herbal compound to treat cutaneous leishmaniasis.
Cite this article:
Ghuffran Muhammed Hassan, Hayder Z. Ali. Ex vivo study of Anti-leishmanial activity of Artemisinin against Leishmania tropica amastigote. Research J. Pharm. and Tech. 2020; 13(8):3787-3791. doi: 10.5958/0974-360X.2020.00670.8
Cite(Electronic):
Ghuffran Muhammed Hassan, Hayder Z. Ali. Ex vivo study of Anti-leishmanial activity of Artemisinin against Leishmania tropica amastigote. Research J. Pharm. and Tech. 2020; 13(8):3787-3791. doi: 10.5958/0974-360X.2020.00670.8 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-8-43
REFERENCES:
1. Showler AJ, Boggild AK. Cutaneous leishmaniasis in travellers: a focus on epidemiology and treatment in 2015.Curr Infect Dis Rp. 2015; 17(7):37.
2. Subathra DC, Harini S, Renuka EJ, et al. Leishmaniasis: A review on global epidemiological trends. Res J Pharm Tech. 2014; 7(5): 569-574.
3. Salam N, Al-Shaqha WM, Azzi A. Leishmaniasis in the Middle East: incidence and epidemiology. PLoS Negl Trop Dis. 2014; 8(10): e3208.
4. Alvar, J Yactayo S and Bern C. Leishmaniasis and poverty. Trends Parasitol.2006; 22 (12): 552-557.
5. Den Boer M Davidson RN. Treatment options for visceral leishmaniasis. Expert Rev Anti Infect Ther. 2006; 4(2):187-97.
6. Moghaddas E, Khamesipour A, Mohebali M, Fata A. Iranian Native Plants on Treatment of Cutaneous Leishmaniosis: A Narrative Review. Iran J Parasitol. 2017; 12(3):312.
7. Wong YK, Xu C, Kalesh KA, et al. Artemisinin as an anticancer drug: recent advances in target profiling and mechanisms of action. Med Res Rev. 2017; 37(6):1492-517.
8. Heydari FE, Ghaffarifar F, Soflaei S, et al. Comparison between in vitro effects of aqueous extract of Artemisia seiberi and artemisinin on Leishmania major. Jundishapur J Nat Pharm Prod. 2013; 8 (2): 70.
9. Loo CS,Lam NS, Yu D, et al. Artemisinin and its derivatives in treating protozoan infections beyond malaria. Pharmacol Res.2017; 117:192-217.
10. Berens RL, Brun R, Krassner SM. A simple monophasic medium for axenic culture of hemoflagellates. J Parasito. 1976; 62(3):360-5.
11. Kamil MM, Ali HZ. Using PCR for detection of cutaneous leishmaniasis in Baghdad. 2016; IJS.57(2B):1125-30.
12. Efferth T. Cancer combination therapies with artemisinin-type drugs. Biochem Pharmaco. 2017;139:56-70.
13. Habibi P, Sadjjadi S, Owji M,et al. Characterization of in vitro cultivated amastigote like of Leishmania major: a substitution for in vivo studies.2008; IJP.6-15.
14. Ghaffarifar F, Heydari FE, Dalimi A, et al. Evaluation of apoptotic and antileishmanial activities of Artemisinin on promastigotes and BALB/C mice infected with Leishmania major. Iran J Parasitol. 2015; 10(2):258.
15. Rouzer CA, Jacobs AT, Nirodi CS, et al. RAW264.7 cells lack prostaglandin-dependent autoregulation of tumor necrosis factor-α secretion. J Lipid Res. 2005; 46(5):1027-37.
16. Li R-J, Gao CY, Guo C, et al. The Anti-inflammatory Activities of Two Major Withanolides from Physalis minima Via Acting on NF-κB, STAT3, and HO-1 in LPS-Stimulated RAW264.7 Cells Inflammation. 2017; 40(2):401-13.
17. Pimpinelli S, Bonaccorsi S, Fanti L, et al. Preparation and analysis of Drosophila mitotic chromosomes. 2000; Drosophila protocols.3-23.
18. Zanatta G, Steffens D, Braghirolli DI, et al. Viability of mesenchymal stem cells during electrospinning. Braz J Med Biol Res. 2012; 45(2):125-30.
19. Sen R, Bandyopadhyay S, Dutta A, et al. Artemisinin triggers induction of cell-cycle arrest and apoptosis in Leishmania donovani promastigotes. J Med Microbiol. 2007; 56(9):1213-8.
20. Want MY, Islamuddin M, Chouhan G, et al. Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasis. Colloids and Surfaces B: Biointerfaces. 2015; 130:215- 21.
21. Wink M. Medicinal plants: a source of anti-parasitic secondary metabolites. Molecules. 2012; 17(11):12771-91.
22. Merly L, Smith SL. Murine RAW 264.7 cell line as an immune target: are we missing something? Immunopharmacology and Immunotoxicology. 2017; 39(2):55-8.
23. Mesa LE, Vasquez D, Lutgen P, et al. In vitro and in vivo antileishmanial activity of Artemisia annua L. leaf powder and its potential usefulness in the treatment of uncomplicated cutaneous leishmaniasis in humans. Rev Soc Bras Med Trop. 2017; 50(1):52-60.
24. Haniloo A, Nemati S, Nahrevanian H, et al. In Vivo and In Vitro Investigation on Anti-Leishmanial Efficacy of Artemisinin on Iranian Strain of Leishmania major. Adv Stud Med Sci. 2016; 4(1):1-11.
25. Ganguly S, Bandyopadhyay S, Bera A, et al. Antipromastigote activity of an ethanolic extract of leaves of Artemisia indica. Indian J Pharmacol. 2006; 38(1):64-5.
26. Erel O, Kocyigit A, Bulut V, et al. Reactive nitrogen and oxygen intermediates in patients with cutaneous leishmaniasis. Mem Ins Oswaldo Cruz. 1999; 94(2):179-83.
27. Ebrahimisadr P, Ghaffarifar F, Hassan ZM. In-vitro evaluation of antileishmanial activity and toxicity of artemether with focus on its apoptotic effect. IJPR. 2013; 12(4):903.
28. Straimer J, Gnädig NF, Witkowski B, et al. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015; 347(6220):428-31.
29. Hassan GM, Ali HZ. In-vitro effects of the Artemisinin on L. tropica promastigotes. (IOSR-JPBS). 2017; 12 (6): 82-6.
30. Colineau L, Clos J, Moon KM. Leishmania donovani chaperonin 10 regulates parasite internalization and intracellular survival in human macrophages. Med Microbiol Immunol. 2017; 206(3):235-57.
31. Sen R, Ganguly S, Saha P, et al. Efficacy of artemisinin in experimental visceral leishmaniasis. Int J Antimicrob Agents. 2010; 36(1):43-9.
32. Marquis J-F Gros P. Intracellular Leishmania: your iron or mine? Trends Microbiol. 2007; 15(3):93-5.
33. Das NK, Biswas S, Solanki S, et al. Leishmania donovani depletes labile iron pool to exploit iron uptake capacity of macrophage for its intracellular growth. Cell Microbiol. 2009; 11(1):83-94.
34. Rahaman M, Ghosh S, Chowdhury LD, et al. Evaluation of anti- leishmanial activity of artemisinin combined with amphotericin B or miltefosine in Leishmania donovani promastigotes. IJBCP. 2014; 3(4): 125-132.
35. Bora KS, Sharma A. The genus Artemisia: a comprehensive review. Pha Biol. 2011; 49(1):101-9.
36. Nemati S, Nahrevanian H, Haniloo A, et al. Investigation on nitric oxide and C-reactive protein involvement in antileishmanial effects of artemisinin and glucantim on cutaneous leishmaniasis. Adv Studies Biol. 2013; 5:27-36.